Innate Pharma (IPHA) Return on Assets (2020 - 2025)

Innate Pharma has reported Return on Assets for 6 years, with the latest figure at 0.01% in Q4 2025.

• For the quarter ending Q4 2025, Return on Assets fell 1.0% year-over-year to 0.01%; the trailing twelve-month figure through Dec 2025 stood at 0.01% (down 1.0% YoY), and the FY2022 full-year result was 0.0%, changed 0.0% from the prior year.
• Return on Assets for Q4 2025 stood at 0.01%, down from 0.01% in the prior quarter.
• The five-year high for Return on Assets was 0.0% in Q4 2022, with the low at 0.01% in Q4 2025.
• Historically, Return on Assets has averaged 0.0% across 5 years, with a median of 0.0% in 2021.
• Annual changes were most pronounced in 2021 — Return on Assets changed 0 bps — and 2024, when it slipped 1 bps.
• Innate Pharma's Return on Assets stood at 0.0% in 2021, then surged by 99 bps to 0.0% in 2022, then plunged by 471 bps to 0.0% in 2023, then sank by 2734 bps to 0.01% in 2024, then plunged by 96 bps to 0.01% in 2025.
• The last three Return on Assets figures came in at 0.01% (Q4 2025), 0.01% (Q2 2025), and 0.01% (Q4 2024), per Business Quant data.